Actinium Pharmaceuticals Inc.
ATNM | AMEX
$1.20
$0 (0.00%)
Sep 22, 2026, 10:39 AM ET · Market open
Market Data
Market Cap $37.65M
Enterprise Value $2.52M
Beta 0.02
Average Volume 128.26K
Shares Outstanding (Diluted) 31.41M
Shares Change YoY 0.68%
Institutional Ownership 16.97%
Exchange AMEX
ISIN US00507W2061
Price Performance
Price Change 1M 9.1%
Price Change 3M 17.6%
Price Change 6M 11.1%
Price Change YTD -12.4%
Price Change 1Y -26.4%
Price Change 3Y -81.0%
Price Change 5Y -87.6%
1M CAGR (ann.) 50.5%
1Y CAGR (ann.) -27.3%
5Y CAGR (ann.) -27.3%
All-Time CAGR -23.2%
Valuation
PE Ratio 3.33
Forward PE N/A
PEG Ratio 0.01
Forward PEG -0.01
PS Ratio 1.07
Forward PS 1.90
PB Ratio 1.24
P/FCF Ratio -1.62
P/Adj. FCF Ratio -1.60
P/OCF Ratio -1.67
EV/Sales 0.07
EV/EBIT -0.15
EV/EBITDA 0.22
EV/FCF -0.11
Earnings Yield 30.0%
FCF Yield -61.8%
Adj. FCF Yield -62.4%
Financial Health
Net Cash $35.13M
Total Debt $1.34M
Cash & Short-Term Investments $36.47M
Total Assets $40.16M
Current Ratio 4.08
Quick Ratio 4.08
Debt / Equity Ratio 0.04
Debt / EBITDA 0.12
Debt / FCF -0.06
OCF / Debt -16.90
Interest Coverage 0.00
Altman Z-Score -10.85
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 101.1%
Operating Profit Margin 27.2%
EBITDA Margin 34.7%
Net Profit Margin 32.2%
FCF Margin -66.3%
Adj. FCF Margin -67.0%
SBC / Revenue 0.7%
SBC Impact (per share) -1.1%
Returns
Return on Assets 28.2%
Return on Equity 83.4%
Return on Invested Capital 30.2%
Return on Capital Employed 30.9%
Return on Tangible Assets 28.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 820.4%
Revenue CAGR 5Y 108.6%
Revenue CAGR 10Y 51.4%
EPS CAGR 3Y 114.2%
EPS CAGR 5Y 33.2%
EPS CAGR 10Y 33.3%
FCF CAGR 3Y 18.3%
FCF CAGR 5Y -23.9%
FCF CAGR 10Y -5.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y -57.4%
Revenue Growth Next 3Y 62.8%
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.25
EPS Growth Est (next Q) 56.3%
Revenue Est (next Q) $1.25M
Revenue Growth Est (next Q) 1284.4%
Fair Value Estimates
Graham Number $2.80
Graham Upside 133.3%
Lynch Fair Value $9
Lynch Upside 650.0%
Price Target $11.07
Price Target Upside 822.5%
Cash Flow
Operating Cash Flow $-22.66M
Free Cash Flow $-23.25M
Adj. Free Cash Flow $-23.5M
FCF Per Share -$0.74
OCF Per Share -$0.72
OCF/S Ratio -64.6%
Income Statement
Revenue $35.09M
Gross Profit $485K
Operating Income $9.56M
EBITDA $11.6M
Net Income $11.31M
EPS (Diluted) $0.36
Revenue / Employee $1.3M
Profit / Employee $418.81K
Employees 27
Add to Watchlist
Select watchlists to add or remove ATNM